Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 601

The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.

Screening for Vulnerability in Older Cancer Patients: The ONCODAGE Prospective Multicenter Cohort Study

Open access
Soubeyran, Pierre, Bellera, Carine, Goyard, Jean, Heitz, Damien, Curé, Hervé, Rousselot, Hubert, Albrand, Gilles, Servent, Véronique, Jean, Olivier Saint, van Praagh, Isabelle, Kurtz, Jean-Emmanuel, Périn, Stéphane, Verhaeghe, Jean-Luc, Terret, Catherine, Desauw, Christophe, Girre, Véronique, Mertens, Cécile, Mathoulin-Pélissier, Simone, Rainfray, Muriel·2014·PLoS ONE

Abstract

BACKGROUND: Geriatric Assessment is an appropriate method for identifying older cancer patients at risk of life-threatening events during therapy. Yet, it is underused in practice, mainly because it is time- and resource-consuming. This study aims to identify the best screening tool to identify older cancer patients requiring geriatric assessment by comparing the performance of two short assessment tools the G8 and the Vulnerable Elders Survey (VES-13). PATIENTS AND METHODS: The diagnostic accuracy of the G8 and the (VES-13) were evaluated in a prospective cohort study of 1674 cancer patients accrued before treatment in 23 health care facilities. 1435 were eligible and evaluable. Outcome measures were multidimensional geriatric assessment (MGA), sensitivity (primary), specificity, negative and positive predictive values and likelihood ratios of the G8 and VES-13, and predictive factors of 1-year survival rate. RESULTS: Patient median age was 78.2 years (70-98) with a majority of females (69.8%), various types of cancer including 53.9% breast, and 75.8% Performance Status 0-1. Impaired MGA, G8, and VES-13 were 80.2%, 68.4%, and 60.2%, respectively. Mean time to complete G8 or VES-13 was about five minutes. Reproducibility of the two questionnaires was good. G8 appeared more sensitive (76.5% versus 68.7%, P = 0.0046) whereas VES-13 was more specific (74.3% versus 64.4%, P<0.0001). Abnormal G8 score (HR = 2.72), advanced stage (HR = 3.30), male sex (HR = 2.69) and poor Performance Status (HR = 3.28) were independent prognostic factors of 1-year survival. CONCLUSION: With good sensitivity and independent prognostic value on 1-year survival, the G8 questionnaire is currently one of the best screening tools available to identify older cancer patients requiring geriatric assessment, and we believe it should be implemented broadly in daily practice. Continuous research efforts should be pursued to refine the selection process of older cancer patients before potentially life-threatening therapy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0115060

Cites

40 of 40 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 40 references

Cited by

See all 601

Metadata

Authors
Soubeyran, P., Bellera, C., Goyard, J., Heitz, D., Curé, H., Rousselot, H., Albrand, G., Servent, V., Jean, O. S., van Praagh, I., Kurtz, J.-E., Périn, S., Verhaeghe, J.-L., Terret, C., Desauw, C., Girre, V., Mertens, C., Mathoulin-Pélissier, S., & Rainfray, M.
Venue
PLoS ONE
Published
2014-12-11
Volume
9
Issue
12
Pages
e115060
ISSN
1932-6203 (ISSN-L)
OpenAlex
W2167333057
Cited by
601
References
40
FWCI
13.02
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Screening for Vulnerability in Older Cancer Patients: The ONCODAGE Prospective Multicenter Cohort Study. https://app.cochat.ai/papers/10.1371/journal.pone.0115060
The paper
Soubeyran, P., Bellera, C., Goyard, J., Heitz, D., Curé, H., Rousselot, H., Albrand, G., Servent, V., Jean, O. S., van Praagh, I., Kurtz, J.-E., Périn, S., Verhaeghe, J.-L., Terret, C., Desauw, C., Girre, V., Mertens, C., Mathoulin-Pélissier, S., & Rainfray, M. (2014). Screening for Vulnerability in Older Cancer Patients: The ONCODAGE Prospective Multicenter Cohort Study. PLoS ONE. https://doi.org/10.1371/journal.pone.0115060

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.